Mr Mrs Miss Ms Dr Other

Miss
Ruby
Mullens

Trainee Patent Attorney

Manchester Office

Life sciences

Telephone. +44(0) 161 247 4900
Email. rmullens@hgf.com
Vcard
Linkedin

Experience

Ruby graduated in 2023 with a first class Master's degree in Biochemistry from the University of Oxford, where she was awarded scholarships and prizes for academic performance. She since joined HGF's Manchester office in January 2025 as a Trainee Patent Attorney in the Life Science team.

She has a broad technical background, having studied genetics, molecular & cellular biology, metabolic processes, macromolecular structures, drug design, chemical pharmacology, bacterial warfare & antibiotic resistance, and biochemical methods.

During her Master's, she undertook a research project in Neurobiology at the Szele Lab, University of Oxford. Here she explored the role of tumour-associated lncRNAs in neural migration using a range of in-vitro and in-vivo gene editing techniques. In this same year, she also carried out a comprehensive review of research on β2-adrenoreceptor signaling in skeletal muscle, providing valuable insights into its therapeutic potential for glucometabolic regulation.

Her special interests and expertise lie in anti-infectives, human metabolism, cellular signalling, cancer biology, disease pathogenesis, and anti-infectives at the molecular and cellular level.

Specialisms

Industries

Services

Qualifications

Trainee

MBIOCHEM

MBiochem in Molecular and Cellular Biochemistry, University of Oxford (First Class Honours)

OTHER

Supplemental Subject in Chemical Pharmacology (Distinction)

Recognition

Nuffield Scholarship in Biochemistry, St Hilda's College, University of Oxford

Porter Prize for Performance, Department of Biochemistry, University of Oxford

Proxime Accessit Gibbs Prize for Performance, Department of Biochemistry, University of Oxford

Related News

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

Agritech Thymes: A review of protection for gene edited plants

As we head into a new season, it’s a good time to revisit the current status of protection for Essentially Derived Varieties (EDVs) and plants derived from New Genomic Techniques …

Read article

Avoiding Legal Pitfalls: The Notting Hill Bag Company's Costly Mistake

[2025] EWHC 1793 (IPEC) – Natasha Courtenay-Smith and Notting Hill Bag Company Limited v The Notting Hill Shopping Bag Company Limited, Nangialai Takanai, The Notting Hill Shopper Bag Ltd, Ehsanullah …

Read article
Event - 12th September 2025

Wolters Kluwer Breakfast Panel on AI & IP at AIPPI

Sofie McPherson, Patent Director at HGF, will be moderating a special breakfast panel session hosted by Wolters Kluwer at the AIPPI World Congress in Yokohama on 15 September 2025. Session …

Event details

T1465/23 – No Narrowing by Description—EPO Board Terminates Inventive Step Analysis for Arbitrary Modifications Citing G1/24 and G1/19

“The potential patentability of a specific narrow embodiment…cannot render a claim allowable which, due to its breadth, encompasses a multitude of other, non-inventive embodiments” – r. 3.5. Background EP3113515 was …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us